Free Whitepaper: Collaborating to End Racial Disparities in Clinical Trials
Learn how biopharma and health centers can come together to improve health equity
The par8o Research Network (PRN) aims to increase both access to and diversity in clinical trials by connecting health centers with clinical research opportunities.
For health centers, par8o offers a way for their patients to be informed of clinical trials that are nearby and relevant to them. Health centers can connect their patients to research without the operational burden of becoming a trial site themselves.
For biopharmaceutical research companies, par8o works with health centers to identify relevant patients based on clinical data and coordinates with their trusted providers to inform them of research opportunities. America’s health centers treat patients that are disproportionately poor, racially and ethnically diverse, and disease-burdened. par8o helps make research efforts more accurately reflect the populations they are ultimately looking to serve.
par8o analyzes EHR data to identify trial participant candidates. Depending on the implementation, health centers can let par8o identify and qualify patients automatically against trial criteria, or do it themselves.
Patient referrals are everyday activities for primary care facilities. By leveraging this workflow, we make it easy for health centers to participate in research - and easy for trial sites to receive pre-screened, quality trial candidates.
Today, health center involvement in research is minimal. All patients deserve to know when a trial is happening nearby that’s relevant to their disease state. All patients deserve the choice to participate.
par8o works with health centers to align trials with health center populations.
Patients are identified by searching EHR data for key eligibility criteria, such as diagnosis codes.
Patients are contacted for initial trial awareness/education and to determine participation interest.
Interested, qualified patients are referred to the triavl site coordinator. par8o closes the loop with the health center to keep informed of patient status with the trial.